Drug Development Fellow for Childhood Cancer Trials

VHIR-RRHH-FOR-003 vs01

TheVall d'Hebron Research Institute

(VHIR) is a public sector institution that

promotes and develops the research,

innovation and biosanitary teaching of the

Vall d’Hebron University Hospital. Through

the excellence of our research, we identify

problems of society and we contribute to

spread them around the world.

In April 2015, the Vall d’Hebron

Research Institute (VHIR) obtained

the recognition of the European

Commission HR Excellence.

This recognition proves that VHIR

endorses the general principles of the

European Charter for Researchers and

a Code of Conduct for the Recruitment

of Researchers (Charter & Code) .

VHIR embraces Equality and

Diversity. As reflected in our values

we work toward ensuring inclusion

and equal opportunity in

recruitment, hiring, training, and

management for all staff within the

organization, regardless of gender,

civil status, family status, sexual

orientation, religion, age, disability

or race.

Drug Development Fellow for Childhood Cancer Trials Translational Research in Child and Adolescent Cancer Group

VHIR offers a vacant position for a Clinical Research Fellow in Paediatric Haematology and Stem Cell

Transplantation within the Translational Research in Cancer and Blood disorders in pediatrics

JOB DESCRIPTION

Education and qualifications : Required:

Degree in Medicine

Specialist training in Paediatrics or Hematology (via MIR or equivalent)

Experience and knowledge : Required:

At least 1-year experience in Paediatric Haematology

Desired:

Experience in red blood cell disorders, mainly sickle cell disease

Training in biomedical research, genomics, statistical analysis (R statistical test)

Experience in Research in Paediatrics

Good communication skills and good team player

Conversation/Discussion oral level in medical English

• VHIR-RRHH-FOR-003 vs01

TheVall d'Hebron Research Institute

(VHIR) is a public sector institution that

promotes and develops the research,

innovation and biosanitary teaching of the

Vall d’Hebron University Hospital. Through

the excellence of our research, we identify

problems of society and we contribute to

spread them around the world.

In April 2015, the Vall d’Hebron

Research Institute (VHIR) obtained

the recognition of the European

Commission HR Excellence.

This recognition proves that VHIR

endorses the general principles of the

European Charter for Researchers and

a Code of Conduct for the Recruitment

of Researchers (Charter & Code) .

VHIR embraces Equality and

Diversity. As reflected in our values

we work toward ensuring inclusion

and equal opportunity in

recruitment, hiring, training, and

management for all staff within the

organization, regardless of gender,

civil status, family status, sexual

orientation, religion, age, disability

or race.

Main responsibilities and duties : Labour conditions: -

Part time position: 32,5 hours/week

• Start: Inmediately
• Temporary contract. 12 months (renewable 12 extra months)
• Gross annual salary: 27.000€.

What can we offer? -

Incorporation to Vall d’Hebron Research Institute (VHIR), a public sector institution that promotes and develops the biomedical research, innovation and teaching at Vall d'Hebron University Hospital (HUVH), the biggest hospital of Barcelona and the largest of Catalan Institute of Health (ICS).

• A scientific environment of excellence, highly dynamic, where high-end biomedical projects are continuously developed.

The Paediatric Haematology and Oncology Division of Vall d’Hebron Hospital treats around 120 children and adolescents with cancer

as well as up to 500 new patients with haematological conditions and performs 40 stem cell transplantations per year. The unit is part

of the European Innovative Therapies for Children with Cancer (ITCC) consortium and two European Reference Networks (Paed-Can

and EuroBloodNet) and has an ambitious clinical research program including patient registries, early and late phase trials, a

personalised medicine programme and multiple lines of research in stem cell transplant, sarcomas, neuroblastoma, CNS tumours

and rare anaemia disorders.

All research is conducted through the Translational Research in Child and Adolescent Cancer Group of VHIR. There are 30 early

consultants, 2 study coordinators, 1 data manager and 2 research nurses.

His/her main role will be:

• Support Clinical coordination of a European Clinical Research project on Artificial Intelligence on genomics for sickle cell

disease for personalized medicine.

• Recruitment and study-related activities including laboratory coordination of patients enrolled in the clinical Research protocol
• VHIR-RRHH-FOR-003 vs01

TheVall d'Hebron Research Institute

(VHIR) is a public sector institution that

promotes and develops the research